Prostate cancer
Abstract Prostate cancer is the most frequent tumor found in men worldwide and in Mexico in particular. Age and family history are the main risk factors. The diagnosis is made by prostate biopsy in patients with abnormalities detected in their prostate-specific antigen (PSA) levels or digital rectal exam (DRE). This article reviews screening and diagnostic methods as well as treatment options for patients diagnosed with prostate cancer.
Saved in:
Main Authors: | Castillejos-Molina,Ricardo Alonso, Gabilondo-Navarro,Fernando Bernardo |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Instituto Nacional de Salud Pública
2016
|
Online Access: | http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0036-36342016000200279 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Low-dose diethylstilbestrol for heavily pretreated metastatic castration-resistant prostate cancer
by: Verduzco-Aguirre,Haydeé C., et al.
Published: (2022) -
Prostatic paracoccidioidomycosis: differential diagnosis of prostate cancer
by: Lopes,Daniel Lima, et al.
Published: (2009) -
Prostate cancer screening in low- and middle- income countries: the Mexican case
by: Lajous,Martin, et al.
Published: (2019) -
Tuberculous prostatitis mimicking metastatic prostate cancer
by: Aslan,Serdar, et al.
Published: (2022) -
Prostatic specific antigen for prostate cancer detection
by: Nogueira,Lucas, et al.
Published: (2009)